PHARMASCROLL
[email protected] Mail Us
  • Home
  • About Us
    • Mission and Vision
    • Our Team
    • Why PharmaScroll
  • Business Intelligence
  • Social Media Analytics
    • SocialBI
  • Market Research Services
  • Newsroom
    • Blog
    • Press Release
    • Recent News
      • Neuroscience
        • Migraine
        • Multiple Sclerosis
        • Alzheimer’s
        • Parkinson’s
        • Epilepsy
        • Schizophrenia
        • Depression
        • ADHD
      • Respiratory
        • COPD
        • Asthma
        • Pulmonary Fibrosis
        • Cystic fibrosis
        • Rhinitis
      • Oncology
      • Diabetes
  • Careers
  • Contact Us
PHARMASCROLL
  • Home
  • About Us
    • Mission and Vision
    • Our Team
    • Why PharmaScroll
  • Business Intelligence
  • Social Media Analytics
    • SocialBI
  • Market Research Services
  • Newsroom
    • Blog
    • Press Release
    • Recent News
      • Neuroscience
        • Migraine
        • Multiple Sclerosis
        • Alzheimer’s
        • Parkinson’s
        • Epilepsy
        • Schizophrenia
        • Depression
        • ADHD
      • Respiratory
        • COPD
        • Asthma
        • Pulmonary Fibrosis
        • Cystic fibrosis
        • Rhinitis
      • Oncology
      • Diabetes
  • Careers
  • Contact Us
[email protected] Mail Us
HomeNewsRespiratoryCOPD
  • NICE advises restricted use of antibiotics for COPD

    • July 10, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • Bellerophon to Present Positive Results from Phase 2 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with COPD at ATS Conference

    • May 16, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • AstraZeneca’s Fasenra Fails in Phase III COPD Trial

    • May 11, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • Verona Pharma to Present Clinical Trial Data of RPL554 at ATS (American Thoracic Society 2018) Conference

    • May 9, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • Verona Pharma to Mark its Presence at BioEquity Europe 2018

    • May 5, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • Trelegy Ellipta gains expanded indication in the US for the treatment of patients with COPD

    • April 25, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • Novartis updates Launch Timeline for Advair Copy to 2019

    • April 22, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • GSK Appoints Senior Executive from Roche to Accelerate Pipeline Growth

    • April 20, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • Trelegy Ellipta – IMPACT Study Shows Significant Benefits in COPD Patients

    • April 19, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
Newsletter
Recent Posts
  • Artificial Intelligence predicts the risk of recurrence of breast cancer, highlights ESMO study
  • Sentiment Analysis for HealthCare – Why it is important and how it can be captured?
  • Role of Artificial Intelligence in Pharmaceutical Industry
  • Pharmacovigilance – How Social Media Listening can help in it?
  • 5 Things Pharmaceutical Sector should focus in Post-Pandemic Era

Contact Us

   [email protected]
   +91 9311760222
   +91 9618379037

   U.S Address: 1209 Orange Street,
City of Wilmington,New Castle,
Delaware 19801

Indian Address: First Office,2nd Floor, Plot No:14, behind Dena Bank,Madhapur, Telangana 500081

Recent Tweets

  • PharmaScroll's SocialBI mines over 5 Mn patient & physician conversations & analyses them using AI/ML algorithms to… https://t.co/OIogEs5IGE3 days ago
  • The investigational gene treatment valoctocogene roxaparvovec by BioMarin Pharmaceutical Inc. has received a positi… https://t.co/mjI6hamVgD5 days ago

Recent Posts

  • Artificial Intelligence predicts the risk of recurrence of breast cancer, highlights ESMO study
  • Sentiment Analysis for HealthCare – Why it is important and how it can be captured?
  • Role of Artificial Intelligence in Pharmaceutical Industry

News Letter

© 2022 Copyright. All rights reserved
SPEAK TO AN EXPERT